Call for tenders Supplies
Purchase of hepatitis A vaccines and hepatitis B vaccines
Notice published in French. The AI analysis summarises it for you in your language.
Tenders due in 32 days — 26 November 2026 at 11:15
“I want this contract”: tracking, reminders and a bid file prepared by AI (eligibility, schedule, cover letter, technical proposal).
- Public buyer
- Ministère de la Défense
Evere - Place of performance
- 1140 Evere, Brussels-Capital
not published: buyer's address - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 23 October 2026
- Notice language
- French
What is the authority looking for?
Supplies · Produits pharmaceutiques, vaccins
L’achat de vaccins contre l’hépatite A et de vaccins contre l’hépatite B selon un marché pluriannuel (48 mois) au sein de la Défense
Where and when?
1140 Evere, Brussels-Capital (buyer's address)
Tenders due in 32 days : 26 November 2026 at 11:15 Belgian time
Site visit and deadline for questions: stated in the specifications, not in the notice.
What budget?
Amount not published in the notice. The AI analysis and comparable tenders give an order of magnitude.
Why is this tender relevant to me?
Create your free account : we compare every tender with your trade and your area.
Can I consider bidding?
The AI analysis extracts the participation conditions, the contractor approval and the required documents. See the analysis and the verdict for your company
Nothing is assumed: what the notice does not say is marked "to check".
What do I need to do?
1. Read the analysis · 2. Check that you meet the conditions · 3. Prepare the response · 4. Submit on the official platform before the deadline.
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
L’achat de vaccins contre l’hépatite A et de vaccins contre l’hépatite B selon un marché pluriannuel (48 mois) au sein de la Défense
2 lots
- 27SC210 - 1
- 27SC210 - 2
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33651600
Winning prices for comparable contracts
- A quarter below
- €290,000
- Median
- €403,000
- A quarter above
- €1,351,075
Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Likely competitors: who wins with this buyer in this field
- SEBIA BENELUX · 1 contract won
- FRESENIUS MEDICAL CARE BELGIUM · 1 contract won
- SIEMENS HEALTHCARE · 1 contract won
- HAUX LIFE SUPPORT GmbH · 1 contract won
- BIO-RAD Laboratories SA · 1 contract won
Partners and subcontractors
Contract too big or too broad for you alone? Bid as a temporary consortium, or offer your services as a subcontractor.
Create your free account to see who is looking for a partner on this contract, and to register.
Companies winning this type of contract in the region
- Celltrion Healthcare Netherlands B.V. · 3 contracts won in 3 years
- CSL BEHRING · 1 contract won in 3 years
- EG · 1 contract won in 3 years
- MSD Animal Health · 1 contract won in 3 years
- Arega Pharma BVBA · 1 contract won in 3 years
- Aurobindo SA · 1 contract won in 3 years
- Laboratoires Delbert SAS · 1 contract won in 3 years
- Pfizer SA · 1 contract won in 3 years
Possible partners for a temporary consortium or subcontracting… and competitors worth knowing.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Immunoglobuline humaine normale pour administration intraveineuse Cliniques universitaires Saint Luc · 22 October 2026 |
CSL BEHRING | €16,277,080 |
| Antimycotica AZ Delta vzw · 21 October 2026 |
Arega Pharma NV Sandoz NV Fresenius Kabi NV Pfizer NV |
€300,945 |
| Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease European Commission, DG SANTE - Health and Food Safety · 1 October 2026 |
Huvepharma EOOD | €2,385,950 |
| Raamovereenkomst voor het leveren van immunoglobulines IV 10% Universitair Ziekenhuis Gent · 24 September 2026 |
CSL BEHRING NV | €27,360,000 |
| Aankoop en levering van plasmaderivaten Algemeen Ziekenhuis Sint-Maria vzw · 15 September 2026 |
CSL BEHRING DEPARTEMENT CENTRAL DE FRACTIONNEMENT Prothya Biosolutions Netherlands B.V. OCTAPHARMA BENELUX |
€18,749,295 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 735321-2026.